# $gmab Genmab's drug Epkinly has failed its first confirmatory test, raising concerns about its efficacy. Meanwhile, new insights into the mechanisms of antibody-drug conjugates from competitors like J&J and Merck have been revealed. ### About $gmab Genmab is a biotechnology company focused on developing and manufacturing antibody therapeutics. ### Engagements: [---] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/interactions.tsv) Current Value: [---] Daily Average: [-----] [--] Month: [-------] +27% [--] Months: [---------] +63% [--] Year: [---------] +25% 1-Year High: [-------] on 2025-09-29 1-Year Low: [---] on 2025-12-14 Engagements by network (24h): YouTube: [--] X: [---] Reddit: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] 1-Year High: [---] on 2025-11-08 1-Year Low: [--] on 2025-04-19 Mentions by network (24h): YouTube: [--] X: [--] Reddit: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning $gmab in the last [--] hours which is down 24% from [--] in the previous [--] hours Daily Average: [--] 1-Year High: [---] on 2025-11-08 1-Year Low: [--] on 2025-04-19 The most influential creators that mention $gmab in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--] | [-----] | [--] | [---] | | [@JacobPlieth](/creator/twitter/JacobPlieth) | [--] | [------] | [--] | [---] | | [@SenefLiveEvents](/creator/twitter/SenefLiveEvents) | [--] | [-----] | [--] | [---] | | [@ChartMill](/creator/twitter/ChartMill) | [--] | [------] | [--] | [--] | | [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | [--] | [---] | [--] | [--] | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | [--] | [-----] | [--] | [--] | | [@kinatsofrim](/creator/twitter/kinatsofrim) | [--] | [---] | [--] | [--] | | [@investseekers](/creator/twitter/investseekers) | [--] | [-----] | [--] | [--] | [View More](/list/creators/$gmab/100) ### Sentiment: 91%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/sentiment.tsv) Current Value: 91% Daily Average: 83% [--] Month: 81% -1% [--] Months: 81% +6% [--] Year: 81% +2% 1-Year High: 100% on 2025-02-15 1-Year Low: 42% on 2025-11-29 Most Supportive Themes: - Earnings Calendar Mentions: (33%) A list of companies with upcoming earnings reports. - Antibody-Drug Conjugate (ADC) Mechanisms: (33%) Discussion of the mechanisms behind antibody-drug conjugates, a type of cancer therapy. Most Critical Themes: - Epkinly Trial Failure: (33%) Genmab's drug Epkinly has failed a confirmatory test. ### Top $gmab Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "Earnings Calendar $FN $RMBS $IDXX $PLTR $TER $TSN $LITE $AMD $AMGN $CRUS $MRK $TTWO $PFE $ADM $GOOG $GOOGL $LLY $SITM $NYT $NVS $GSK $BOOT $STE $CME $NVO $ABBV $ORLY $BE $GMAB $MPWR $RL $ILMN $CAH $NVST $ARWR $AMZN $BMY $NVT $CBOE $SPX $NYSE $NDX $IBD $IWM $XLY $IBB" [X Link](https://x.com/STaylor76084368/status/2017748467754365206) [@STaylor76084368](/creator/x/STaylor76084368) 2026-01-31T23:54Z [---] followers, [---] engagements "With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK have been revealed. Quite amazing given the recent $GMAB news. Via @ApexOnco - https://www.oncologypipeline.com/apexonco/node/1874 https://www.oncologypipeline.com/apexonco/node/1874" [X Link](https://x.com/JacobPlieth/status/2016896251233534381) [@JacobPlieth](/creator/x/JacobPlieth) 2026-01-29T15:28Z 31.7K followers, [----] engagements "$GMAB $ABBV Epkinly fails its first confirmatory test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test" [X Link](https://x.com/MarcJacksonLA/status/2013354728483160517) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-01-19T20:55Z [----] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Genmab's drug Epkinly has failed its first confirmatory test, raising concerns about its efficacy. Meanwhile, new insights into the mechanisms of antibody-drug conjugates from competitors like J&J and Merck have been revealed.
Genmab is a biotechnology company focused on developing and manufacturing antibody therapeutics.
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Month: [-------] +27%
[--] Months: [---------] +63%
[--] Year: [---------] +25%
1-Year High: [-------] on 2025-09-29
1-Year Low: [---] on 2025-12-14
Engagements by network (24h): YouTube: [--] X: [---] Reddit: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-08
1-Year Low: [--] on 2025-04-19
Mentions by network (24h): YouTube: [--] X: [--] Reddit: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $gmab in the last [--] hours which is down 24% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-11-08
1-Year Low: [--] on 2025-04-19
The most influential creators that mention $gmab in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @NightOwlBiotech | [--] | [-----] | [--] | [---] |
| @JacobPlieth | [--] | [------] | [--] | [---] |
| @SenefLiveEvents | [--] | [-----] | [--] | [---] |
| @ChartMill | [--] | [------] | [--] | [--] |
| @EgidiusLambrech | [--] | [---] | [--] | [--] |
| @MarcJacksonLA | [--] | [-----] | [--] | [--] |
| @kinatsofrim | [--] | [---] | [--] | [--] |
| @investseekers | [--] | [-----] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 91%
Daily Average: 83%
[--] Month: 81% -1%
[--] Months: 81% +6%
[--] Year: 81% +2%
1-Year High: 100% on 2025-02-15
1-Year Low: 42% on 2025-11-29
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Earnings Calendar $FN $RMBS $IDXX $PLTR $TER $TSN $LITE $AMD $AMGN $CRUS $MRK $TTWO $PFE $ADM $GOOG $GOOGL $LLY $SITM $NYT $NVS $GSK $BOOT $STE $CME $NVO $ABBV $ORLY $BE $GMAB $MPWR $RL $ILMN $CAH $NVST $ARWR $AMZN $BMY $NVT $CBOE $SPX $NYSE $NDX $IBD $IWM $XLY $IBB"
X Link @STaylor76084368 2026-01-31T23:54Z [---] followers, [---] engagements
"With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK have been revealed. Quite amazing given the recent $GMAB news. Via @ApexOnco - https://www.oncologypipeline.com/apexonco/node/1874 https://www.oncologypipeline.com/apexonco/node/1874"
X Link @JacobPlieth 2026-01-29T15:28Z 31.7K followers, [----] engagements
"$GMAB $ABBV Epkinly fails its first confirmatory test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test https://www.oncologypipeline.com/apexonco/epkinly-fails-its-first-confirmatory-test"
X Link @MarcJacksonLA 2026-01-19T20:55Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$gmab